Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

Abstract

The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.

Keywords

• ocrelizumab
• multiple sclerosis
• recurrent multiple sclerosis
• primary progressive multiple sclerosis
• monoclonal antibody